Breast Density, Elevated Breast Cancer Risk Highest in Hispanic Women

TON - March 2017, Vol 10, No 2 - Breast Cancer
Meg Barbor, MPH

Cape Town, South Africa—Breast density, which can affect the visualization of mammography, is one of the strongest and most consistent risk factors for breast cancer. Women with the highest mammographic density (≥75%) are at a 4- to 6-fold increased risk for developing breast cancer compared with women with the least dense tissue.

Although an estimated 50% of women in the United States have dense breasts, data on ethnic variations in breast density and breast cancer risk are limited. Research on this topic has seldom included minorities, such as black and Hispanic women, according to a group of researchers at Georgetown University in Washington, DC.

The team, led by Bridget Oppong, MD, Assistant Professor of Surgery, Division of Breast Surgery, Georgetown University Hospital of Surgery, Washington, DC, conducted an investigation into the differences in breast cancer risk among varying ethnic populations and presented the results in a poster at the American Association for Cancer Research International Conference on New Frontiers in Cancer Research.

The researchers reviewed breast density recorded at initial mammographic screening in women who presented to the Capital Breast Care Center and Georgetown University Hospital from 2010 to 2014. From imaging reports, they recorded the American College of Radiology BI-RADS density categories; 1, fatty; 2, scattered fibroglandular densities; 3, heterogeneously dense; and 4, extremely dense.

From 2010 to 2014, mammographic density was recorded for 2147 women: 940 (43.8%) black, 893 (41.6%) Hispanic, and 314 (14.6%) white. The investigators observed high breast density (categories 3 and 4) in Hispanic, premenopausal, nonobese women without children (P <.001), and found that these characteristics were predictive of high mammographic density. Obese women were 70% less likely to have high breast density than nonobese women.

In this analysis, Hispanic women were found to have the highest breast density, followed by black women, with white women having the lowest. The breast density and cancer interplay may be a crucial element in addressing racial and ethnic disparities in breast cancer outcomes, but further investigation of the impact of obesity on breast density in the understudied Hispanic population is needed.

“As there is a paucity of reporting on mammographic density in minority women, these data presented are valuable, especially as we are able to have a comparison group of whites,” the researchers noted.

Related Items
Long-Term Data from the TEAM Trial Support Individualized Adjuvant Endocrine Therapy Strategy for Postmenopausal Women with HR-Positive Early Breast Cancer
TON Web Exclusives published on December 28, 2017 in Breast Cancer
Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2
TON Web Exclusives published on December 28, 2017 in Breast Cancer
Results of DATA Study Failed to Show Benefits for Extended Endocrine Therapy in Women with Breast Cancer
TON Web Exclusives published on December 28, 2017 in Breast Cancer
BRCA1/2 Status Affects Response to Polychemotherapy in Triple-Negative Breast Cancer
TON Web Exclusives published on December 28, 2017 in Breast Cancer
Do Hormonal Contraceptives Increase the Risk for Breast Cancer?
TON Web Exclusives published on December 28, 2017 in Breast Cancer
HER2 CAR T-Cell Delivery for Treating Multifocal Brain Metastases
TON Web Exclusives published on December 28, 2017 in Breast Cancer
Questions About Treating Patients on a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Last modified: March 7, 2017